The
Australian Clinical Trials Registry is now called the
Australian New Zealand Clinical Trials Registry. Please be aware
that the new web address is
www.anzctr.org.au. The
purpose and function of the ANZCTR remain unchanged.
The CONSORT
Group are delighted to announce a redesign of the CONSORT
Statement
website:
http://www.consort-statement.org
The CONSORT
Statement is an evidence-based, minimum set of recommendations for
reporting randomized controlled trials. It offers a standard way for
authors to prepare reports of trial findings, facilitating their
complete and transparent reporting, and aiding their critical
appraisal and interpretation.
Some highlights
of the site:
-
The definitive
version of the CONSORT Statement
-
The CONSORT
checklist: examples and explanation of each item
-
Translations
of the CONSORT Statement into ten languages
-
Extensions to
the main CONSORT Statement for different trial designs,
interventions and data types
-
Browsable
bibliographies of the evidence underpinning CONSORT
-
History and
impact of CONSORT
-
News articles
on the developments of CONSORT
-
A full
glossary of terms
-
A simple yet
powerful search facility
Cochrane Pregnancy & Childbirth library update Issue 1,
2008
A. NEW REVIEWS:
(1) Intracervical
prostaglandins for induction of labour (Boulvain M, Kelly A, Irion O)
(2) Prophylactic
oral betamimetics for preventing preterm labour in singleton
pregnancies (Whitworth M, Quenby S)
(3) Techniques for
caesarean section (Hofmeyr GJ, Mathai M, Shah A, Novikova N)
(4) Third trimester
antiviral prophylaxis for preventing maternal genital herpes simplex
virus (HSV) recurrences and neonatal infection (Hollier LM, Wendel GD)
B. SUBSTANTIALLY
UPDATED REVIEWS
(1) Antioxidants
for preventing pre-eclampsia (Rumbold A, Duley L, Crowther CA, Haslam
RR)
(2) Biophysical
profile for fetal assessment in high risk pregnancies (Lalor JG,
Fawole B, Alfirevic Z, Devane D)
(3) Interventions
for the treatment of twin-twin transfusion syndrome (Roberts D,
Neilson JP, Kilby M, Gates S)
(4) Support for
mothers, fathers and families after perinatal death (Flenady V, Wilson
T)
C.
NON-SUBSTANTIVELY UPDATED REVIEWS
(1) Induction of
labour for suspected fetal macrosomia (Irion O, Boulvain M)
(2) Maternal oxygen
administration for fetal distress (Fawole B, Hofmeyr GJ)
(3) Vaginal
chlorhexidine during labour to prevent early-onset neonatal Group B
streptococcal infection (Stade B, Shah V, Ohlsson A)
D. NEW PROTOCOLS
(1) Folate
supplementation in pregnancy (Haider BA, Humayun Q, Bhutta ZA)
(2) Local
anaesthetic wound infiltration and abdominal nerves block during
caesarean section for postoperative pain relief (Bamigboye AA, Hofmeyr
GJ)
(3) Modifications
of maternal caffeine intake for improving pregnancy outcome (Jahanfar
S, Sharifah H)
(4) Music during
caesarean section under regional anesthesia for improving maternal and
infant outcomes (Laopaiboon M, Lumbiganon P, Martis R, Vatanasapt P,
Somchiwong B)
(5) Nitric oxide
donors for cervical ripening and induction of labour (Kelly AJ,
Kavanagh J)
(6) Tight versus
very tight control of mild-moderate pre-existing or non-proteinuric
gestational hypertension for improving outcomes (Nabhan AF, Adel A)
(7) Treatments for
breast engorgement during lactation (Mangesi L, Muzonzini G)
(8) Use of
intra-uterine pressure catheter (IUPC) versus external tocodynamometry
(TOCO) during labour for reducing adverse outcomes (Bakker JJH,
Janssen PF, Mol BWJ, Papatsonis D, van Lith JMM, van der Post JAM)
E. Reviews for
which new search conducted but no new trials identified:
(1) Abdominal
decompression in normal pregnancy
(2) Antenatal
education for self-diagnosis of the onset of active labour at term
(3) Bed rest during
pregnancy for preventing miscarriage
(4) Bed rest in
hospital for suspected impaired fetal growth
(5) Bed rest with
or without hospitalisation for hypertension during pregnancy
(6) Betamimetics
for suspected impaired fetal growth
(7) Caesarean
section versus vaginal delivery for preventing mother to infant
hepatitis C virus transmission
(8) Discontinuation
of epidural analgesia late in labour for reducing the adverse delivery
outcomes associated with epidural analgesia
(9) Fetal
manipulation for facilitating tests of fetal wellbeing
(10) Garlic for
preventing pre-eclampsia and its complications
(11) Prophylactic
ergometrine-oxytocin versus oxytocin for the third stage of labour
